Reports & Outcomes

The 1-in-20 Problem: Why Therapists Can't Spot Deteriorating Clients Without Data

· By The Team

Clinicians identify only 1 in 20 deteriorating clients without monitoring. Routine outcome monitoring can cut that rate dramatically.

A Sobering Statistic

In 2005, Hannan and colleagues published a finding that continues to challenge the clinical profession: clinicians accurately identify only 1 in 20 (5%) of their clients who are deteriorating. That means for every 20 clients who are getting worse in treatment, the treating clinician recognizes the deterioration in just one of them.

This isn't a reflection of clinical incompetence. These were experienced clinicians working within their scope of practice. The problem is structural: the human brain, even a highly trained one, struggles to detect gradual deterioration when it sees a client for 50 minutes once a week.

The Scale of the Problem

Approximately 5-10% of clients deteriorate during treatment -- they leave treatment worse than when they started (Lambert, 2010). For a clinician with a caseload of 25 clients, that means 1-3 clients may be actively getting worse at any given time.

Without systematic monitoring, the clinician is likely to catch the deterioration in perhaps one of those cases -- and only when it becomes severe enough to be obvious in session. The other cases progress undetected, sometimes culminating in crisis, dropout, or a client who simply stops showing up.

Lambert's (2010) research on routine outcome monitoring demonstrated that systematic measurement can reduce client deterioration from approximately 20% to 5-10%. When clinicians receive algorithmic feedback about client trajectories, they intervene earlier and more effectively.

Reviewing a bar chart and data sheets

Structured measurement turns scattered impressions into a trend line.

Why Clinical Intuition Falls Short

The 1-in-20 finding isn't about poor clinicians. It's about cognitive limitations that affect all humans:

Anchoring bias. Once a clinician forms an initial impression of a client's trajectory (usually positive -- most clinicians believe their clients are improving), subsequent information is interpreted through that lens. A bad session gets attributed to a rough week, not a downward trend.

The weekly snapshot problem. A 50-minute session provides a single data point per week. That's 0.7% of a client's waking hours. Mood, behavior, and functioning fluctuate continuously between sessions, and a single observation can't capture the trajectory.

Retrospective recall bias. When clients report on their week at the start of a session, they're reconstructing from memory. Research shows that retrospective self-reports correlate only r = 0.4 to 0.6 with real-time ecological momentary assessment data (Shiffman et al., 2008). Clients don't accurately remember how they felt -- they report how they feel now and project backward.

Positive presentation bias. Many clients, especially those with attachment difficulties or people-pleasing patterns, present better in session than they actually feel. They want to show progress, please their clinician, or avoid difficult conversations about lack of improvement.

What Measurement-Based Care Actually Shows

Measurement-based care (MBC) -- the systematic use of standardized outcome measures to track client progress -- has a strong evidence base:

  • MBC clients are 3.5x less likely to deteriorate and 2x as likely to achieve clinically significant improvement compared to treatment-as-usual (Lambert et al., 2003).
  • Digital MBC reduced treatment duration by 2.4 sessions while maintaining equivalent outcomes, suggesting more efficient treatment (Shimokawa et al., 2010).
  • Routine outcome monitoring reduces deterioration from approximately 20% to 5-10% when clinicians receive algorithmic alerts about at-risk clients (Lambert, 2010).

The evidence is robust enough that organizations like the American Psychological Association have endorsed MBC as a best practice. Yet adoption remains low.

The Adoption Gap

Despite strong evidence, only 17-37% of practitioners use standardized outcome measures in routine practice. A study by Jensen-Doss and colleagues found that 62% of clinicians cite MBC as "too time-consuming" as their primary barrier.

This creates a paradox: clinicians know they're missing deterioration (the research is widely cited), they know MBC helps (the evidence is clear), but they don't use MBC because the administrative burden of implementing it manually is too high on top of their existing documentation load.

Adding a standardized outcome measure to every session, scoring it, tracking it longitudinally, and interpreting the trajectory adds 5-10 minutes per client per session. Across a caseload of 25 clients, that's 2-4 additional hours per week of administrative work -- in a profession already overwhelmed by paperwork.

Abstract woven data ribbons

Continuous data weaves many small signals into one clearer picture.

Beyond Traditional MBC: Continuous Between-Session Data

Traditional MBC relies on in-session measurement: a standardized questionnaire administered at the start of each appointment. This is better than no measurement, but it still provides only weekly data points.

Ecological Momentary Assessment (EMA) -- real-time data collection between sessions through digital tools -- offers a fundamentally different approach. Instead of asking a client to retrospectively summarize their week, EMA captures data in the moment: mood ratings, behavioral observations, journal entries, activity completion, and even passive data from wearables.

The research on EMA in clinical care is compelling:

  • EMA predicted treatment outcomes with R-squared = 0.34, compared to R-squared = 0.12 for baseline measures alone. That's nearly three times the predictive power.
  • EMA compliance rates of 75-85% demonstrate high feasibility -- clients are willing to engage with between-session tracking when it's integrated into their daily routine.
  • EMA detected emerging deterioration 17 days before clinical presentation (Wichers et al., 2016), providing a critical early warning window for clinical intervention.
  • Digital phenotyping (passive data collection from smartphones and wearables) predicted worsening outcomes with AUC = 0.82, suggesting that behavioral patterns captured passively can identify risk with high accuracy.
  • GPS mobility reduction correlated with higher distress scores (r = -0.58), showing that physical behavior patterns are meaningfully linked to client distress severity.

Abstract network of linked nodes

Patterns emerge across many points rather than a single snapshot.

Continuous Signal vs. Snapshots

The difference between traditional MBC and continuous between-session monitoring is the difference between a photograph and a video. A photograph (weekly in-session measure) shows where the client is at one point in time. A video (continuous between-session data) shows the trajectory, the variability, and the patterns.

Consider a client whose standardized outcome score has been stable at 12 for three weeks. With traditional MBC, this looks like a plateau. But continuous between-session data might reveal that:

  • Mood has been declining steadily each evening
  • Sleep quality (captured by a wearable) has deteriorated over the past 10 days
  • Journaling frequency has dropped from daily to every 3-4 days
  • Activity completion has fallen from 80% to 40%

Each of these signals, individually, might not trigger alarm. Together, they paint a picture of emerging deterioration that the weekly in-session measure hasn't yet captured.

Making It Work Without Adding Burden

The irony of MBC is that the solution to the detection problem (measurement) creates more of the problem that causes burnout (administrative work). This is why digital, automated approaches are essential.

Effective between-session monitoring should:

  1. Capture data passively or with minimal client effort -- mood ratings, activity completion, and wearable data should flow automatically.
  2. Suggest patterns, never conclusions -- the clinician shouldn't have to wade through raw data. The most software should do is draft possible trends and themes as suggestions for the clinician to confirm or discard. What any of it means clinically is the clinician's read alone.
  3. Integrate with session preparation -- relevant between-session data should appear in the clinician's pre-session view, not in a separate dashboard.
  4. Operate on consent -- clients must control what data is shared and retain the ability to withdraw consent at any time.

When these conditions are met, MBC stops being an additional administrative task and becomes an embedded part of the clinical workflow. The clinical judgment always stays with the clinician; the software only organizes the data and offers suggestions — deciding what counts as a signal is the clinician's call.

The 1-in-20 Problem Is Solvable

The gap between what clinicians detect intuitively (5% of deteriorating clients) and what measurement-based approaches detect (up to 90-95%) is too large to ignore. The research is unambiguous: without systematic monitoring, most deterioration goes undetected.

The tools to close this gap now exist. Between-session data collection, paired with software that drafts possible patterns and suggestions for the clinician's review, can supplement clinical intuition without adding to the administrative burden that drives burnout. I've gone deeper on the clinical evidence for between-session data and on why therapist-connected apps outperform standalone tools.

The question for individual practitioners is whether to continue relying on clinical judgment alone -- knowing it catches only 1 in 20 -- or to adopt tools that bring the other 19 into view. Getting the documentation and report load down is what makes room for that measurement in the first place — you can see how Soma drafts the write-up you review and sign.


References: Hannan et al. (2005), Clinical Psychology & Psychotherapy; Lambert (2010), Prevention of Treatment Failure; Lambert et al. (2003), Journal of Clinical Psychology; Jensen-Doss et al., Assessment; Shimokawa et al. (2010), Journal of Consulting and Clinical Psychology; Wichers et al. (2016), Acta Psychiatrica Scandinavica; Shiffman et al. (2008), Annual Review of Clinical Psychology.

Ian Vardy
Ian Vardy
Founder & CEO, Soma Health

Ian is building Soma — AI tools that give clinicians their time back by drafting documentation, so therapists and psychologists can focus on their clients. He writes about clinical reporting, AI, and running a clinician-first software company.

See how Soma drafts reports →